IPCA asks USFDA to clarify on Hydroxychloroquine risk

Hydroxychloroquine, besides being administered as an anti-malarial
drug, is also used as a chronic therapy by patients suffering from
auto immune diseases such as RA and Lupus. In the recent months the
drug has been used in several countries including India and US in the
treatment of critically ill Covid-19 patients.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ipca-asks-usfda-to-clarify-on-hydroxychloroquine-risk/articleshow/75462945.cms

Comments

Popular posts from this blog

Sunday Worship Service

Teva Regulatory Affairs Associate Job Vacancy – Apply Online

Teva Regulatory Affairs Job Vacancy – Pharma Candidates Apply